93 related articles for article (PubMed ID: 10975395)
1. My4+/LeuM3- molecule and CD19 antigen are down-modulate by low affinity Fc gamma receptor II (CD32) stimulation on CD56-positive B-lymphoma cells.
Ikemoto T; Nakagawa T; Hatanaka M; Hasegawa M; Kageyama T; Hirano M; Shimizu A
Leuk Lymphoma; 2000 Sep; 39(1-2):157-64. PubMed ID: 10975395
[TBL] [Abstract][Full Text] [Related]
2. A cell surface antigen that cross-reacts with My4, a monoclonal antibody to CD14, is expressed on human monoblastic cell line U937, B-lymphoma cells, and polymorphonuclear leukocytes.
Ikemoto T; Nakagawa T; Hatanaka M; Hasegawa M; Kageyama T; Hirano M; Shimizu A
Neoplasma; 1997; 44(5):289-94. PubMed ID: 9473787
[TBL] [Abstract][Full Text] [Related]
3. Fc gamma receptor II (CD32) on malignant B cells influences modulation induced by anti-CD19 monoclonal antibody.
Vervoordeldonk SF; Merle PA; van Leeuwen EF; van der Schoot CE; von dem Borne AE; Slaper-Cortenbach IC
Blood; 1994 Mar; 83(6):1632-9. PubMed ID: 7510146
[TBL] [Abstract][Full Text] [Related]
4. Fc gammaRIIb inhibits both B cell receptor- and CD19-induced Ca2+ mobilization in Fc gammaR-transfected human B cells.
Koncz G; Gergely J; Sármay G
Int Immunol; 1998 Feb; 10(2):141-6. PubMed ID: 9533441
[TBL] [Abstract][Full Text] [Related]
5. The antibody MY4 recognizes CD14 on porcine monocytes and macrophages.
Ziegler-Heitbrock HW; Appl B; Käfferlein E; Löffler T; Jahn-Henninger H; Gutensohn W; Nores JR; McCullough K; Passlick B; Labeta MO
Scand J Immunol; 1994 Nov; 40(5):509-14. PubMed ID: 7526441
[TBL] [Abstract][Full Text] [Related]
6. My4 antibody staining of non-Hodgkin's lymphomas.
Medeiros LJ; Herrington RD; Gonzalez CL; Jaffe ES; Cossman J
Am J Clin Pathol; 1991 Mar; 95(3):363-8. PubMed ID: 1705092
[TBL] [Abstract][Full Text] [Related]
7. Effective lysis of lymphoma cells with a stabilised bispecific single-chain Fv antibody against CD19 and FcgammaRIII (CD16).
Bruenke J; Barbin K; Kunert S; Lang P; Pfeiffer M; Stieglmaier K; Niethammer D; Stockmeyer B; Peipp M; Repp R; Valerius T; Fey GH
Br J Haematol; 2005 Jul; 130(2):218-28. PubMed ID: 16029450
[TBL] [Abstract][Full Text] [Related]
8. CD14 is expressed and functional in human B cells.
Ziegler-Heitbrock HW; Pechumer H; Petersmann I; Durieux JJ; Vita N; Labeta MO; Ströbel M
Eur J Immunol; 1994 Aug; 24(8):1937-40. PubMed ID: 7520002
[TBL] [Abstract][Full Text] [Related]
9. MY4 expression on B-lymphocyte malignancies may be associated with a more adverse prognosis.
Warzynski MJ; Otto RN; Steingart RH; White CF; Rosen MH; Hetzel PC; Flatow FA; Podgurski AE; Johnson ML
Leuk Res; 1991; 15(5):357-65. PubMed ID: 2046387
[TBL] [Abstract][Full Text] [Related]
10. The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
Hadley AG; Zupanska B; Kumpel BM; Leader KA
Immunology; 1992 Jul; 76(3):446-51. PubMed ID: 1356095
[TBL] [Abstract][Full Text] [Related]
11. [Regulation of Fc receptor expression by immune complexes on neutrophils and U937 cells].
Guo LH; Zhang W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Oct; 26(5):510-4. PubMed ID: 15562762
[TBL] [Abstract][Full Text] [Related]
12. CD19 is functionally and physically associated with surface immunoglobulin.
Pesando JM; Bouchard LS; McMaster BE
J Exp Med; 1989 Dec; 170(6):2159-64. PubMed ID: 2479707
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Fc gamma receptor mediated T-cell activation by two purified CD3 x CD19 bispecific monoclonal antibodies with hybrid Fc domains.
Haagen IA; Geerars AJ; Bast EJ; de Gast GC; van de Winkel JG; de Lau WB
Ther Immunol; 1994 Oct; 1(5):279-87. PubMed ID: 7584502
[TBL] [Abstract][Full Text] [Related]
14. Variation of LPS-binding capacity, epitope expression, and shedding of membrane-bound CD14 during differentiation of human monocytes.
Pedron T; Girard R; Chaby R
J Immunol; 1995 Aug; 155(3):1460-71. PubMed ID: 7543522
[TBL] [Abstract][Full Text] [Related]
15. Abnormal blood monocytes in chronic lymphocytic leukemia.
Flieger D; Ziegler-Heitbrock HW
Cancer Res; 1988 Sep; 48(17):4812-6. PubMed ID: 3409222
[TBL] [Abstract][Full Text] [Related]
16. Aggregated IgG inhibits the differentiation of human fibrocytes.
Pilling D; Tucker NM; Gomer RH
J Leukoc Biol; 2006 Jun; 79(6):1242-51. PubMed ID: 16543402
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of Fc gamma RII on human natural killer cells.
Metes D; Galatiuc C; Moldovan I; Morel PA; Chambers WH; DeLeo AB; Rabinowich H; Schall R; Whiteside TL; Sulica A
Nat Immun; 1994; 13(6):289-300. PubMed ID: 7894200
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous expression of CD32 and CD32-mediated growth suppression in human myeloma cells.
Zheng X; Abroun S; Otsuyama K; Asaoku H; Kawano MM
Haematologica; 2006 Jul; 91(7):920-8. PubMed ID: 16818279
[TBL] [Abstract][Full Text] [Related]
19. Physiological up-regulation of inhibitory receptors Fc gamma RII and CR1 on memory B cells is lacking in SLE patients.
Isaák A; Gergely P; Szekeres Z; Prechl J; Poór G; Erdei A; Gergely J
Int Immunol; 2008 Feb; 20(2):185-92. PubMed ID: 18182380
[TBL] [Abstract][Full Text] [Related]
20. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia.
Horton HM; Bernett MJ; Pong E; Peipp M; Karki S; Chu SY; Richards JO; Vostiar I; Joyce PF; Repp R; Desjarlais JR; Zhukovsky EA
Cancer Res; 2008 Oct; 68(19):8049-57. PubMed ID: 18829563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
